Lista de obras - C Espejo - Dominio Público Uruguay

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

scientific article published on 07 April 2020

Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.

artículo científico publicado en 2001

Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

artículo científico publicado en 2014

Antimyelin antibodies with no progression to multiple sclerosis.

artículo científico publicado en 2007

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

artículo científico publicado en 2014

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

artículo científico publicado en 2017

Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation

artículo científico publicado en 2017

Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.

artículo científico publicado en 2015

CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis.

artículo científico publicado en 2004

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

scientific article published on 21 October 2008

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

artículo científico publicado en 2017

Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.

artículo científico publicado en 2017

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

artículo científico publicado en 2017

Dalfampridine in multiple sclerosis: From symptomatic treatment to immunomodulation ⬇️

artículo científico publicado el 25 de junio de 2011

Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis

artículo científico publicado en 2001

Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design

artículo científico publicado en 2015

Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions

artículo científico publicado en 2018

Expression of chemokine receptors in the different clinical forms of multiple sclerosis

artículo científico publicado en 2002

Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation

artículo científico publicado en 2006

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.

artículo científico publicado en 2015

GDP-l-fucose synthase is a CD4 T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis

article

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

scientific article published on 14 March 2017

Hsp70 regulates immune response in experimental autoimmune encephalomyelitis

artículo científico publicado en 2014

IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2004

Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.

artículo científico publicado en 2011

Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.

artículo científico publicado en 2003

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis

article

Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis

artículo científico publicado en 2020

Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis

artículo científico publicado en 2002

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

scientific article published on 11 June 2019

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

artículo científico publicado en 2015

Myeloid-derived suppressor cells are generated during retroviral transduction of murine bone marrow.

artículo científico publicado en 2012

Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.

artículo científico publicado en 2017

Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis

artículo científico publicado en 2016

Neurofilament light chain level is a weak risk factor for the development of MS.

artículo científico publicado en 2016

Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats

artículo científico publicado en 2000

Plasma chitotriosidase activity in multiple sclerosis.

artículo científico publicado en 2009

Regulatory lymphocytes are key factors in MHC-independent resistance to EAE

artículo científico publicado en 2014

SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes

scientific article published on 24 July 2019

Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis

artículo científico publicado en 2016

Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis

artículo científico publicado en 2013

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis

artículo científico publicado en 2013

Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse

scientific article published on 01 February 2002

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

artículo científico publicado en 2019

The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO

scientific article published on 04 August 2015

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

artículo científico publicado en 2018

Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis

artículo científico publicado en 2005

Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen

artículo científico publicado en 2009

Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.

artículo científico publicado en 2009

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.

artículo científico publicado en 2012

Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice.

artículo científico publicado en 2001

Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

artículo científico publicado en 2002

Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients.

artículo científico publicado en 2013

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

artículo científico publicado en 2011

[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]

artículo científico publicado en 2012

Lista de obras de C Espejo

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.

Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

Antimyelin antibodies with no progression to multiple sclerosis.

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation

Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.

CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis.

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Dalfampridine in multiple sclerosis: From symptomatic treatment to immunomodulation ⬇️

Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis

Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design

Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions

Expression of chemokine receptors in the different clinical forms of multiple sclerosis

Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.

GDP-l-fucose synthase is a CD4 T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

Hsp70 regulates immune response in experimental autoimmune encephalomyelitis

IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis

Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.

Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis

Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis

Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

Myeloid-derived suppressor cells are generated during retroviral transduction of murine bone marrow.

Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.

Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis

Neurofilament light chain level is a weak risk factor for the development of MS.

Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats

Plasma chitotriosidase activity in multiple sclerosis.

Regulatory lymphocytes are key factors in MHC-independent resistance to EAE

SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes

Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis

Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis

Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis

Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen

Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.

Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice.

Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients.

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]